YB-1 and MTA1 protein levels and not DNA or mRNA alterations predict for prostate cancer recurrence

Christine Moore Sheridan(University of California, San Francisco), Davide Ruggero(University of California, San Francisco)
Oncotarget
March 3, 2015
Cited by 26


Related Papers